Taiyen Biotech Co., Ltd. (TPE:1737)

Market Cap	6.58B
Revenue (ttm)	3.24B
Net Income (ttm)	364.42M
Shares Out	200.00M
EPS (ttm)	1.82
PE Ratio	18.08
Forward PE	n/a
Dividend	1.30 (3.95%)
Ex-Dividend Date	Aug 20, 2024

Volume	46,948
Average Volume	65,203
Open	32.90
Previous Close	32.90
Day's Range	32.75 - 32.90
52-Week Range	29.15 - 35.85
Beta	0.18
RSI	55.39
Earnings Date	Aug 1, 2025

About Taiyen Biotech

Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. Its products portfolio includes various salt and seawater chemical products; bath salt, bath salt milk, salt soap, algae soap, and shampoo; beverage and raw drinking water; skin care; toothpaste, salt mouthwash, and eye glass care solution; salt for washing fruits and vegetables; and food and food additives. The company also manufactures western medicine, environmental pharmaceuticals, and cosmetics. In addition, it imports and exports da...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1952
• Employees: 450
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1737

Financial Performance

In 2024, Taiyen Biotech's revenue was 3.24 billion, a decrease of -5.01% compared to the previous year's 3.41 billion. Earnings were 371.52 million, an increase of 23.68%.